Neogen Corporation
corporate_fare Company Profile
Neogen Corporation (NASDAQ:NEOG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for NEOG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-07, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NEOG spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Neogen Q1 FY2027: Revenue Up 6.5%, Operating Loss Narrows to $1.8M, Genomics Sale Still Pending
- Neogen Lifts FY2027 Outlook on Q1 Beat and New Imaging Partnership
- Neogen Q1 Revenue Beats, Raises FY27 Guidance on Strong Core Growth
- FDA Warning Letter: Neogen's Hycoat Linked to 20 Horse Deaths, Contamination Found
- Annual Report Highlights Significant Net Loss Reduction, Internal Control Remediation, and Debt Reduction
Financial Snapshot
Short Interest & Short Volume
4.79 days to coverFINRA reported short interest of 12,709,583 shares in NEOG as of the October 30, 2026 settlement, a 6.6% increase from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 58.0% of NEOG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.